Press Releases and Stories

An international research team led by HKUST has identified a blood protein that plays a key role in the pathogenesis of Alzheimer’s disease.

President XI Jinping made an official visit to the Hong Kong Center for Neurodegenerative Diseases (HKCeND) at the Hong Kong Science and Technology Park yesterday in the company of officials from the Central Government and the HKSAR Government.

Researchers at the Hong Kong Center for Neurodegenerative Diseases (HKCeND), founded by The Hong Kong University of Science and Technology (HKUST), have made promising breakthroughs in early diagnosis and therapeutic treatment of Alzheimer’s disease (AD) that

A novel brain-wide genome-editing technology offers immense potential to be translated as a novel long-acting therapeutic treatment for Alzheimer’s patients.

A research team led by HKUST's VPRD Prof. Nancy IP has developed a simple yet highly effective Alzheimer’s blood test from Chinese patient data for the first time.

Researchers at the Hong Kong University of Science and Technology (HKUST) have identified new therapeutic targets for Alzheimer’s disease (AD) by studying the patients’ brain with a newly-developed methodology.

The ability to undertake in vivo imaging of a living brain in a mammalian animal model is crucial for elucidating how the brain functions.

The Hong Kong University of Science and Technology (HKUST) signed a landmark Memorandum of Understanding (MoU) together with Boston Children’s Hospital – a Harvard Medical School Teaching Hospital (Harvard), the Paul F.